Cargando…
Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study
BACKGROUND: Although long-term use of benzodiazepines and benzodiazepine receptor agonists (BZDs) has been associated with an increased risk of dependence, the incidence, details of clinical manifestations, and triggering factors of withdrawal symptoms associated with long-term BZD use at common cli...
Autores principales: | Inoue, Yuichi, Takaesu, Yoshikazu, Koebis, Michinori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045275/ https://www.ncbi.nlm.nih.gov/pubmed/33853571 http://dx.doi.org/10.1186/s12888-021-03196-0 |
Ejemplares similares
-
Eszopiclone for late-life insomnia
por: McCrae, Christina S, et al.
Publicado: (2007) -
Eszopiclone: its use in the treatment of insomnia
por: Monti, Jaime M, et al.
Publicado: (2007) -
Eszopiclone versus zopiclone in the treatment of insomnia
por: Pinto, Luciano Ribeiro, et al.
Publicado: (2016) -
Management of insomnia in elderly patients using eszopiclone
por: Kirkwood, Cynthia, et al.
Publicado: (2010) -
Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients
por: Buxton, Orfeu M, et al.
Publicado: (2017)